Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Tech Partners with CHOP on Software for Personalized Drug Dosing

NEW YORK (GenomeWeb News) - Bayer Technology Services is collaborating with Children’s Hospital of Philadelphia on a research project to develop individualized drug therapies for children, the company said today.
 
BTS will integrate its PK-Sim pharmacokinetic and pharmacodynamic modeling and simulation techniques with CHOP’s “Pediatric Knowledgebase” -- an initiative to create a user-friendly computer interface that will present doctors with patient information and dosing history and use simulations to predict “expected trends in drug plasma concentrations,” the company said.
 
The end result will allow pediatricians to make drug dosing decisions that are tailored to each patient, BTS said.
 
The collaboration will “aim to demonstrate the usefulness of physiology-based modeling in guiding dosing decisions.” said Jörg Lippert, Head of the Systems Biology Group of BTS, in a statement.

Filed under

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.